HVT:NYSEHaverty Furniture Companies, Inc. Analysis
Data as of 2026-06-17 - not real-time
$24.39
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Haverty Furniture is trading near its recent resistance around $24.5 with a bullish MACD histogram and an RSI hovering in the mid‑60s, suggesting modest upward momentum but also hinting at overbought conditions. Revenue growth remains modest at just over 4% year‑over‑year, while operating margins stay thin, keeping profitability fragile. The stock offers an attractive dividend yield of roughly 5.6%, yet the payout ratio exceeds 100%, raising questions about sustainability. Valuation metrics tell a mixed story: the trailing P/E is close to 20, the forward P/E drops to under 10, but the discounted cash flow model pins fair value near $9.4, implying the market price of $24.4 is significantly stretched. Volatility is elevated at over 35% on a 30‑day basis, and beta under 1 indicates the stock moves slightly less than the broader market but still carries cyclical risk. Support sits around $21.1, providing a cushion if sentiment turns, while the broader consumer‑cyclical sector remains sensitive to economic headwinds.
Overall, the combination of high dividend yield, stretched valuation, and a thin profitability profile suggests caution; short‑term bullish technical signals may be offset by fundamental concerns, making a wait‑and‑see stance prudent while monitoring earnings momentum and dividend policy.
Overall, the combination of high dividend yield, stretched valuation, and a thin profitability profile suggests caution; short‑term bullish technical signals may be offset by fundamental concerns, making a wait‑and‑see stance prudent while monitoring earnings momentum and dividend policy.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD histogram indicating short‑term momentum
- RSI in overbought territory suggesting potential pull‑back
- Proximity to resistance level limiting upside
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Modest revenue growth and improving forward earnings
- Attractive forward P/E versus trailing P/E
- High dividend yield offset by unsustainable payout ratio
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Current price far above DCF‑derived fair value
- Cyclical consumer sector exposure
- Dividend payout exceeding earnings, raising sustainability concerns
Key Metrics & Analysis
Financial Health
Revenue Growth4.10%
Profit Margin2.64%
P/E Ratio20.0
ROE6.61%
ROA2.20%
Debt/Equity71.50
P/B Ratio1.3
Op. Cash Flow$43.6M
Free Cash Flow$16.7M
Technical Analysis
TrendNeutral
RSI65.8
Support$21.11
Resistance$24.56
MA 20$23.12
MA 50$22.43
MA 200$23.07
MACDBullish
VolumeStable
Fear & Greed Index91.75
Valuation
Fair Value$9.44
Target Price$29.50
Upside/Downside20.95%
GradeOvervalued
TypeBlend
Dividend Yield5.60%
Risk Assessment
Beta0.90
Volatility36.27%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.